cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
1 own
3 watching
Current Price
$2.39
$-0.09
(-3.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
510.09M
52-Week High
52-Week High
22.22000
52-Week Low
52-Week Low
2.36990
Average Volume
Average Volume
0.13M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization510.09M
icon52-Week High22.22000
icon52-Week Low2.36990
iconAverage Volume0.13M
iconDividend Yield--
iconP/E Ratio--
What does the Stockal+Disclaimer.pdf do?
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
1 year ago
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results PR Newswire DURHAM, N.C. and BEIJING, March 24, 2023 Company maintains priority focus on clinical programs to develop a...
PR Newswire
1 year ago
Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company? Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company? PR Newswire NEW YORK, Aug. 5, 2022 NEW YORK, Aug. 5, 2022 /PRNewswire...
Globe Newswire
2years ago
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the pricing of its upsized initial public offering of 4...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$2.39
$-0.09
(-3.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00